Grufity logoGrufity logo
Stocks
Funds
Screener
Sectors
Watchlists
GMED

GMED - Globus Medical Inc Stock Price, Fair Value and News

$84.78+0.27 (+0.32%)
Delayed

72/100

GMED

STOCK SCORE

High Scoring Large Cap stocks have outperformed low scoring stocks by 90% over last 10 years

72/100

GMED

STOCK SCORE

High Scoring Large Cap stocks have outperformed low scoring stocks by 90% over last 10 years

Price Targets

Target 1Y

Login to View

Target 6M

Login to View

GMED Stock Valuation Analysis

Valuation

Login to View

Max Portfolio %

Login to View

GMED Price Action

Last 7 days

-2.7%

Last 30 days

-3.9%

Last 90 days

-2.2%

Trailing 12 Months

21.7%

GMED RSI Chart

GMED Stock Valuation Analysis

Valuation

Login to View

Max Portfolio %

Login to View

GMED Valuation

Market Cap

11.5B

Price/Earnings (Trailing)

20.99

Price/Sales (Trailing)

3.9

EV/EBITDA

12.34

Price/Free Cashflow

19.48

GMED Price/Sales (Trailing)

The Good, Bad and Ugly

Growth

Profitability

Size

Dilution Risk

Balance Sheet

Momentum

Funds Popularity

Insider Trading

Price Targets

Target 1Y

Login to View

Target 6M

Login to View

GMED Fundamentals

GMED Revenue

Revenue (TTM)

2.9B

Rev. Growth (Yr)

25.73%

Rev. Growth (Qtr)

7.46%

GMED Earnings

Earnings (TTM)

546.4M

Earnings Growth (Yr)

383.07%

Earnings Growth (Qtr)

10.99%

GMED Profitability

EBT Margin

20.59%

Return on Equity

11.95%

Return on Assets

10.3%

Free Cashflow Yield

5.13%

GMED Investor Care

Buy Backs (1Y)

1.66%

Diluted EPS (TTM)

3.93

GMED Alerts

  • 1 major insider sales recently.
  • Big jump in Revenue (Y/Y)
  • Big jump in Earnings (Y/Y)

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs
Net sales
YearQ1Q2Q3Q4
20252.5B2.6B2.8B2.9B
20241.9B2.2B2.5B2.5B
20231.1B1.1B1.2B1.6B
2022961.3M973.9M998.4M1.0B
2021825.8M927.9M941.5M958.1M
2020793.0M747.4M767.3M789.0M
2019721.5M742.7M769.6M785.4M
2018654.6M675.6M693.1M713.0M
2017580.5M595.4M611.5M636.0M
2016552.4M556.3M555.0M564.0M
2015491.8M511.8M531.0M544.8M
2014443.7M450.2M460.8M474.4M
2013396.3M407.3M419.8M434.5M
2012347.9M363.0M373.5M386.0M
2011299.0M309.8M320.7M331.5M
Get all data in R, Python etc through our Historical Stock Data APIs

About Globus Medical Inc

GMED
Globus Medical, Inc., a medical device company, develops and commercializes healthcare solutions for patients with musculoskeletal disorders in the United States and internationally. It offers spine products, such as traditional fusion implants comprising pedicle screw and rod systems, plating systems, intervertebral spacers, and corpectomy devices for treating degenerative and congenital conditions, deformity, tumors, and trauma injuries; treatment options for motion preservation technologies that consist of dynamic stabilization, total disc replacement, and interspinous distraction devices; interventional pain management solutions to treat vertebral compression fractures; and regenerative biologic products comprising of allografts and synthetic alternatives. The company also offers products for the treatment of orthopedic trauma, including fracture plates, compression screws, intramedullary nails, and external fixation systems; and hip and knee joint solutions, including modular hip stems and acetabular cups, as well as posterior stabilizing and cruciate retaining knee arthroplasty implants. In addition, it distributes human cell, tissue, and cellular and tissue-based products. The company sells its products through direct or distributor sales presence, as well as its hip and knee products primarily through independent sales agents. Globus Medical, Inc. was incorporated in 2003 and is headquartered in Audubon, Pennsylvania.
 CEO
 WEBSITEglobusmedical.com
 SECTORHealthcare
 INDUSTRYMedical Devices
 EMPLOYEES2600

Globus Medical Inc Frequently Asked Questions

GMED is the stock ticker symbol of Globus Medical Inc. Every public company that trades on a stock exchange gets a ticker symbol.

As of Fri Mar 13 2026, market cap of Globus Medical Inc is 11.47 Billion. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

As of Fri Mar 13 2026, GMED's PE ratio (Price to Earnings) is 20.99 and Price to Sales (PS) ratio is 3.9. The price to earnings and price to sales ratio are two most important valuation metrics for any company. PE ratio tell us the number of years of earnings investors are ready to pay for owning the company. Historically, S&P500 price to earnings ratio has fallen below 12 during periods of gloom and gone past 30 during periods of euphoria. GMED PE ratio will change depending on the future growth rate expectations of investors.

In the past 10 years, Globus Medical Inc has provided 0.132 (multiply by 100 for percentage) rate of return.